TABLE 1.

Clinicopathologic Characteristics of AS and Types of Platforms Investigated

Case ID	Age	Sex	Previous RT-therapy	Chronic Lymphedema	Primary location	MYC amplified by FISH	MYC amplified by aCGH	Micro-RNA deep sequencing	qRT-PCR
AS3a	58	M	No	No	Femur	NA	Yes	No	Yes
AS4	63	F	Yes	No	Breast	Yes	NA	Yes	No
AS9	70	M	No	No	Thigh	No	No	Yes	Yes
AS10	70	F	Yes	No	Breast	Yes	Yes	No	Yes
AS11	50	M	No	No	Spleen	NA	No	Yes	No
AS15	61	F	Yes	No	Breast	NA	Yes	No	Yes
AS20	56	F	Yes	No	Breast	Yes	Yes	No	Yes
AS27	37	F	No	No	Breast	No	NA	Yes	No
AS29	75	F	Yes	No	Breast	Yes	No	Yes	Yes
AS30	38	F	Yes	No	Head and neck	No	No	Yes	Yes
AS31	79	M	No	No	Scalp	No	NA	Yes	Yes
AS32	76	F	Yes	No	Breast	Yes	Yes	No	Yes
AS38	74	F	Yes	Yes	Forearm	Yes	Yes	Yes	Yes
AS39	84	M	Yes	Yes	Arm	Yes	Yes	Yes	Yes
AS68	80	F	Yes	No	Breast	Yes	Yes	Yes	No
AS70a	38	F	No	No	Breast	Yes	Yes	Yes	Yes
AS73	83	F	Yes	No	Breast	NA	Yes	Yes	No
AS76	76	M	Yes	No	Bladder	NA	No	Yes	No
AS85	76	F	Yes	No	Breast	Yes	NA	Yes	No
AS123	76	F	Yes	No	Breast	No	No	Yes	Yes
AS124	57	M	No	No	Head and neck	NA	No	Yes	No
AS125a	73	F	No	No	Breast	Yes	Yes	No	Yes

Other vascular tumors
	Age	Sex	Histology	Primary location	Micro-RNA deep sequencing	qRT-PCR
AS78	M	68	EHE	Arm	No	Yes
AS80	M	41	Epithelioid hemangioma	Chest wall	Yes	No
AS84	M	31	Epithelioid hemangioma	Metatarsal bone	Yes	No
EHE74	M	44	EHE	Liver	No	Yes

RT, radiation therapy; EHE: epithelioid hemangioendothelioma.

^aPrimary AS tumors that showed MYC amplification by aCGH.